Sleep apnea-induced hypertension: Mechanisms of vascular changes

Expert Review of Cardiovascular Therapy

Volumn 3, Issue 5, 2005, Pages 937-940

  Sharabi, Yehonatan ^a,b   Rabin, Karen ^a   Grossman, Ehud ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Hypertension; Inflammatory mediators; Obstructive sleep apnea; Vasculopathy

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CATECHOLAMINE; CD11 ANTIGEN; CD15 ANTIGEN; ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; NEUROHORMONE; REACTIVE OXYGEN METABOLITE; RENIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR DISEASE; CHEMORECEPTOR; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; ENDOTHELIUM LESION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOXIA; META ANALYSIS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; REVIEW; SLEEP APNEA SYNDROME; SYSTEMATIC REVIEW; VASCULAR DISEASE;

HUMANS; HYPERTENSION; SLEEP APNEA SYNDROMES;

EID: 26844543275     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.3.5.937     Document Type: Review

References (33)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328(17), 1230-1235 (1993).
2. Bixler EO, Vgontzas AN, Lin HM et al. Association of hypertension and sleep-disordered breathing. Arch. Intern. Med. 160(15), 2289-2295 (2000).
3. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am. J. Med. 98(2), 118-128 (1995).
4. Bixler EO, Vgontzas AN, Lin HM et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am. J. Respir. Crit. Care Med. 163(3 Pt. 1), 608-613 (2001).
5. Resta O, Caratozzolo G, Pannacciulli N et al. Gender, age and menopause effects on the prevalence and the characteristics of obstructive sleep apnea in obesity. Eur. J. Clin. Invest. 33(12), 1084-1089 (2003).
6. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 342(19), 1378-1384 (2000).
7. Sharabi Y, Scope A, Chorney N, Grotto I, Dagan Y. Diastolic blood pressure is the first to rise in association with early subclinical obstructive sleep apnea: lessons from periodic examination screening. Am. J. Hypertens. 16(3), 236-239 (2003).
8. Suzuki M, Guilleminault C, Otsuka K, Shiomi T. Blood pressure 'dipping' and 'nondipping' in obstructive sleep apnea syndrome patients. Sleep 19(5), 382-387 (1996).
9. Loredo JS, Ancoli-Israel S, Dimsdale JE. Sleep quality and blood pressure dipping in obstructive sleep apnea. Am. J. Hypertens. 14(9 Pt. 1), 887-892 (2001).
10. Iliescu EA, Lam M, Pater J, Munt PW. Do patients with obstructive sleep apnea have clinically significant proteinuria? Clin. Nephrol. 55(3), 196-204 (2001).
11. Casserly LF, Chow N, Ali S, Gottlieb DJ, Epstein LJ, Kaufman JS. Proteinuria in obstructive sleep apnea. Kidney Int. 60(4), 1484-1489 (2001).
12. Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 22(2), 217-223 (1999).
13. Alchanatis M, Paradellis G, Pini H, Tourkohoriti G, Jordanoglou J. Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration 67(4), 367-371 (2000).
14. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107(20), 2589-2594 (2003).
15. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin. Proc. 79(8), 1036-1046 (2004).
16. Elmasry A, Lindberg E, Hedner J, Janson C, Boman G. Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study. Eur. Respir. J. 19(3), 511-517 (2002).
17. Belozeroff V, Berry RB, Khoo MC. Model-based assessment of autonomic control in obstructive sleep apnea syndrome. Sleep 26(1), 65-73 (2003).
18. Moller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am. J. Hypertens. 16(4), 274-280 (2003).
19. Blankfield RP, Ahmed M, Zyzanski SJ. Effect of nasal continuous positive airway pressure on edema in patients with obstructive sleep apnea. Sleep Med. 5(6), 589-592 (2004).
20. Blankfield RP, Ahmed M, Zyzanski SJ. Idiopathic edema is associated with obstructive sleep apnea in women. Sleep Med. 5(6), 583-587 (2004).
21. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am. J. Respir. Crit. Care Med. 165(5), 670-676 (2002).
22. Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O'Donnell CP. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir. Physiol. Neurobiol. 136(2-3), 167-178 (2003).
23. Shamsuzzaman AS, Winnicki M, Lanfranchi P et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21), 2462-2464 (2002).
24. Yokoe T, Minoguchi K, Matsuo H et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8), 1129-1134 (2003).
25. El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, Grant BJ. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 121(5), 1541-1547 (2002).
26. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J. Appl. Physiol. 94(1), 179-184 (2003).
27. Ohga E, Nagase T, Tomita T et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J. Appl. Physiol. 87(1), 10-14 (1999).
28. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am. J. Respir. Crit. Care Med. 165(7), 934-939 (2002).
29. Minoguchi K, Tazaki T, Yokoe T et al. Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome. Chest 126(5), 1473-1479 (2004).
30. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J. Hypertens. 17(1), 61-66 (1999).
31. Jelic S, Bartels MN, Mateika JH, Ngai P, DeMeersman RE, Basner RC. Arterial stiffness increases during obstructive sleep apneas. Sleep 25(8), 850-855 (2002).
32. Gozal D, Lipton AJ, Jones KL. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 25(1), 59-65 (2002).
33. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe night time hypoxia. Am. J. Respir. Crit. Care Med. 165(1), 67-70 (2002).